CoChat

Norepinephrine transporter occupancy by nortriptyline in patients with depression: a positron emission tomography study with (S,S)-[18F]FMeNER-D2

Open access
Takano, Harumasa, Arakawa, Ryosuke, Nogami, Tsuyoshi, Suzuki, Masayuki, Nagashima, Tomohisa, Fujiwara, Hironobu, Kimura, Yasuyuki, Kodaka, Fumitoshi, Takahata, Keisuke, Shimada, Hitoshi, Murakami, Yoshitaka, Tateno, Amane, Yamada, Makiko, Ito, Hiroshi, Kawamura, Kazunori, Zhang, Ming-Rong, Takahashi, Hidehiko, Kato, Motoichiro, Okubo, Yoshiro, Suhara, Tetsuya · 2014 · The International Journal of Neuropsychopharmacology
Cited by 34

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Norepinephrine transporter (NET) plays important roles in the treatment of various neuropsychiatric disorders, such as depression and attention deficit hyperactivity disorder (ADHD). Nortriptyline is a NET-selective tricyclic antidepressant (TCAs) that has been widely used for the treatment of depression. Previous positron emission tomography (PET) studies have reported over 80% serotonin transporter occupancy with clinical doses of selective serotonin reuptake inhibitors (SSRIs), but there has been no report of NET occupancy in patients treated with relatively NET-selective antidepressants. In the present study, we used PET and (S,S)-[18¹⁸F]FMeNER-D₂ to investigate NET occupancies in the thalamus in 10 patients with major depressive disorder taking various doses of nortriptyline, who were considered to be responders to the treatment. Reference data for the calculation of occupancy were derived from age-matched healthy controls. The result showed approximately 50-70% NET occupancies in the brain as a result of the administration of 75-200 mg/d of nortriptyline. The estimated effective dose (ED₅₀) and concentration (EC₅₀) required to induce 50% occupancy was 65.9 mg/d and 79.8 ng/ml, respectively. Furthermore, as the minimum therapeutic level of plasma nortriptyline for the treatment of depression has been reported to be 70 ng/ml, our data indicate that this plasma nortriptyline concentration corresponds to approximately 50% NET occupancy measured with PET, suggesting that more than 50% of central NET occupancy would be appropriate for the nortriptyline treatment of patients with depression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1017/s1461145713001521

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 34

Metadata

Authors
Takano, H., Arakawa, R., Nogami, T., Suzuki, M., Nagashima, T., Fujiwara, H., Kimura, Y., Kodaka, F., Takahata, K., Shimada, H., Murakami, Y., Tateno, A., Yamada, M., Ito, H., Kawamura, K., Zhang, M.-R., Takahashi, H., Kato, M., Okubo, Y., & Suhara, T.
Venue
The International Journal of Neuropsychopharmacology
Published
2013-12-18
Volume
17
Issue
04
Pages
553-560
ISSN
  • 1461-1457 (ISSN-L)
  • 1469-5111
OpenAlex
W2135165574
Cited by
34
References
7
FWCI
1.74
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Norepinephrine transporter occupancy by nortriptyline in patients with depression: a positron emission tomography study with (S,S)-[18F]FMeNER-D2. https://app.cochat.ai/papers/10.1017/s1461145713001521
The paper
Takano, H., Arakawa, R., Nogami, T., Suzuki, M., Nagashima, T., Fujiwara, H., Kimura, Y., Kodaka, F., Takahata, K., Shimada, H., Murakami, Y., Tateno, A., Yamada, M., Ito, H., Kawamura, K., Zhang, M.-R., Takahashi, H., Kato, M., Okubo, Y., & Suhara, T. (2014). Norepinephrine transporter occupancy by nortriptyline in patients with depression: a positron emission tomography study with (S,S)-[18F]FMeNER-D2. The International Journal of Neuropsychopharmacology. https://doi.org/10.1017/s1461145713001521

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.